Form 4 for CVS CVS Health
Accepted 2026-04-02 16:49:30 ET · period of report 2026-03-31 · accession 0000064803-26-000035 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-02 16:49 | 2026-03-31 | CVS | CAPOZZI HEIDI B | EVP, CHRO | A - Grant | $71.82 | +10.0K | 84.5K | +13% | +$720.0K |
| D | 2026-04-02 16:49 | 2026-04-01 | CVS | CAPOZZI HEIDI B | EVP, CHRO | F - Tax | $72.49 | -1,334 | 13.0K | -9% | -$96.7K |
| D | 2026-04-02 16:49 | 2026-03-31 | CVS | CAPOZZI HEIDI B | EVP, CHRO | A - Grant | $71.82 | +64.7K | 64.7K | New | +$4.64M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock (Restricted) | 2026-03-31 | A | A | 10,025 | $71.82 | 84,450 | D | — | — | (F1) Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027. |
| 2 | Common | Common Stock | 2026-04-01 | F | D | 1,334 | $72.49 | 13,023 | D | — | — | (F2) Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units. |
| 3 | Derivative | Stock Option | 2026-03-31 | A | A | 64,670 | $71.82 | 64,670 | D | $71.82 · 2027-03-31 to 2036-03-31 | 64,670 Common Stock | (F3) Option becomes exercisable in three equal annual installments, commencing 3/31/2027. |